All News

After receiving 4.8 mg of survodutide weekly for 46 weeks, more than half of trial participants achieved weight loss of 15% or more.

Acceptance and commitment therapy can significantly help patients with primary insomnia and secondary symptoms, especially anxiety associated with insomnia and those who have not responded to cognitive behavioral therapy for insomnia.

Black children with sickle cell disease (SCD) face a disproportionate burden of social determinants of health (SDOH), the study found.

The findings suggest existing therapies for other cancers may be helpful in multiple myeloma (MM).

These findings from research into diffuse large B cell lymphoma (DLBCL) are based on analyses of human patients and a murine model.

Older adults and infants were found to have the highest mortality and hospitalization rates of respiratory syncytial virus (RSV).

FDA to import cancer drugs from China; respite programs offer a safe environment for people who experience mental health crisis; White House officials call for more xylazine testing.

The use of probiotics, fecal microbiota transplants, and live biotherapeutics have been effective in phase 3 studies that focus on Clostridioides difficile infection (CDI).

Researchers explained that educational level, duration of disease, and inhaler type may affect adherence in patients with chronic obstructive pulmonary disease (COPD).

This small study showed that individuals who used an app designed specifically for smokers ambivalent about quitting used the app more often and exhibited greater changes in behavior compared with those using a similar nontailored app.

After the Supreme Court ruled reimbursement cuts to 340B hospitals were done unlawfully, CMS is proposing to repay hospitals and providers in the program with a lump sum that has repercussions for other hospitals because of the agency’s need to be budget neutral.

Lesion mapping led researchers to identify a common brain circuit related to epilepsy.

A smartphone app was found to be useful and reliable by clinicians when testing vision for children during the COVID-19 pandemic.

An analysis found that patients with uncontrolled severe asthma have a higher symptom burden compared with those whose severe asthma is controlled, highlighting the need for more innovative treatment options to improve asthma control.

US Senate Majority Leader Chuck Schumer asks the FDA to investigate Prime energy drink; Washington state sees hefty fine for failing to provide mental health resources to incarcerated individuals; a new rule would require companies to disclose use of certain “forever” chemicals.

Despite the need for improved eczema therapies and a rapid increase in available clinical trials, participation remains low.

More attention should be paid to prevent acne scarring and address the psychosocial consequences associated with it, authors argue.

Symptoms initially pointed to toxic alcohol ingestion.

There is no approved treatment for chronic hepatitis D virus infection in the United States, but recent phase 3 trial results showed encouraging safety and efficacy associated with bulevirtide.

The patient in this case experienced significant muscle weakness after emerging from anesthesia.

New data from AIDSVu show significant disparities in the usage of HIV pre-exposure prophylaxis (PrEP). Black and Hispanic/Latinx Americans are underrepresented among PrEP users, despite accounting for a significant portion of new HIV diagnoses.

The US government has set a goal of achieving viral clearance in 80% of patients by 2030.

Investigators stress the importance of ongoing research on the association between depression and pain in patients with sickle cell disease (SCD).

Martin Griesshammer, MD, PhD, Johannes Wesling University Clinic, discusses past and current efforts to improve treatment options for patients with polycythemia vera.

Investigators said it is important for clinicians to interpret scans with knowledge of case-specific context for patients with diffuse large B-cell lymphoma (DLBCL).

The condition was seen in a 75-year-old female patient with a history of epilepsy and hypertension.

The study investigated event rates for several outcomes in the year following a first hospitalization for heart failure (HF), including implementation of guideline-directed medical therapy (GDMT).